Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus. NJPS [Internet]. 31 grudzień 2021 [cytowane 9 czerwiec 2026];36(2):159-64. Dostępne na: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/1520